EMN P/E Ratio Analysis
Updated 105h ago·SEC filings & market data
Key Takeaway
The P/E ratio of 19.2x means investors pay $19.20 for every $1 of current earnings, a standard measure of how expensive a stock is.
Sector Performance
39th percentileEMN
19.2x
Sector Median
23.1x
Sector Avg
33.7x
Prior Period
21.3x(Jul 2026)
Deep Analysis
The P/E ratio of 19.2x means investors pay $19.20 for every $1 of current earnings, a standard measure of how expensive a stock is.
This sits below the sector median of 23.4x, placing EMN at the 38th percentile among peers, so the stock is less expensive than most in its sector. The year-over-year change is not available, while the quarter-over-quarter change is -9.8%, indicating a recent drop in valuation. Historical values show the ratio fell from 21.3x to 19.2x. A below-median level combined with a declining ratio suggests tempered risk, as the stock lacks a premium price and the compression may reflect a cooler outlook rather than a red flag. This metric supports the overall neutral verdict, since valuation is neither stretched enough to warn nor cheap enough to excite.
Frequently Asked Questions
What does the P/E Ratio tell investors about EMN?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
Who are EMN's closest peers by P/E Ratio?
The closest peers by P/E Ratio include: WELL (102.4x), IAC (104.9x), FORM (108.1x), MCHP (113.5x), MTSI (118.9x).
Learn More About P/E Ratio
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master EMN's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full EMN research report →EMN
19.2x
Sector Median
23.1x
Sector Avg
33.7x
How EMN's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.